Usa Financial Portformulas Corp Catalent, Inc. Transaction History

Usa Financial Portformulas Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2021 May 06, 2021	SELL	$101.51 - $125.27 $308,082 - $380,194	-3,035 Closed	0 $0
Q4 2020 Jan 29, 2021	SELL	$85.88 - $105.36 $205,424 - $252,021	-2,392 Reduced 44.08%	3,035 $316,000
Q3 2020 Oct 09, 2020	BUY	$72.74 - $92.5 $61,901 - $78,717	851 Added 18.6%	5,427 $465,000
Q2 2020 Aug 11, 2020	BUY	$48.02 - $79.04 $219,739 - $361,687	4,576 New	4,576 $335,000

511

149M

575K

2.03M

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $11.4B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

Get notified when there are updates to the investment portfolio of Usa Financial Portformulas Corp, based on Form 13F filings with the SEC.

Stay updated on Usa Financial Portformulas Corp with notifications on news.